
Mad Money w/ Jim Cramer 12/16/24
Mad Money w/ Jim Cramer
Opportunities in Vertex and Bristol-Myers Amid Market Adjustments
This chapter explores stock performance and market potential for Vertex and Bristol-Myers, highlighting Vertex's growth and strategic shifts at Bristol-Myers. The analysis suggests both companies present attractive buying opportunities based on their financial metrics and ongoing developments.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.